Molecular predictors of non-muscle invasive bladder cancer progression

被引:0
|
作者
Smal, M. [1 ]
Rolevich, A. [2 ]
Nikitchenko, N. [1 ]
Krasny, S. [2 ]
Goncharova, R. [1 ]
机构
[1] Inst Genet & Cytol NASB, Minsk, BELARUS
[2] NN Alexandrov Natl Canc Ctr Belarus, Lesnoy, Minsk District, BELARUS
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
P12.165.B
引用
收藏
页码:541 / 541
页数:1
相关论文
共 50 条
  • [1] Targeting splicing factors as molecular non-muscle invasive bladder cancer predictors
    Lee, Kyoung-Hwa
    Ku, Ja Hyeon
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 : S715 - S717
  • [2] Molecular Landscape of Non-Muscle Invasive Bladder Cancer
    Meeks, Joshua J.
    Lerner, Seth P.
    [J]. CANCER CELL, 2017, 32 (05) : 550 - 551
  • [3] Molecular Subtypes of Non-muscle Invasive Bladder Cancer
    Lerner, Seth P.
    Robertson, A. Gordon
    [J]. CANCER CELL, 2016, 30 (01) : 1 - 3
  • [4] Predictors of response to BCG therapy in non-muscle invasive bladder cancer
    Radovanovic, Milan
    Petrovic, Milos
    Santric, Veljko
    Zubelic, Aleksa
    [J]. SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2022, 150 (1-2) : 113 - 116
  • [5] Non-Muscle Invasive Bladder Cancer Preface
    Chang, Sam S.
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2013, 40 (02) : XIII - XIII
  • [6] NON-MUSCLE INVASIVE BLADDER CANCER IN 2012
    Esuvaranathan, Kesavan
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 123 - 123
  • [7] Immunotherapy for non-muscle invasive bladder cancer
    Cathomas, R.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 17 - 17
  • [8] The Costs of Non-Muscle Invasive Bladder Cancer
    James, Andrew C.
    Gore, John L.
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2013, 40 (02) : 261 - +
  • [9] Aftercare of non-muscle invasive bladder cancer
    Schulz, G. B.
    Schlenker, B.
    Stief, C. G.
    [J]. UROLOGE, 2019, 58 (08): : 943 - 952
  • [10] Hyperthermia for non-muscle invasive bladder cancer
    Soria, Francesco
    Allasia, Marco
    Oderda, Marco
    Gontero, Paolo
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (03) : 313 - 321